New machine learning algorithm could decide who is best for heart failure treatment
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment




Cardiology Homepage

New 3D bioprinting method can create organs from collagen Major structural protein in the human body

Key success criteria for the creation of an outpatient heart failure clinic Deb Thompson, senior consulting manager for Cardiology at Philips discusses what is required for the efficient management of a multi-disciplinary heart care team

New AI solution identifies high-risk patients from chest X-rays MGH tool may help detect heart disease, lung cancer

Cardiology occupies a unique space in medical informatics Looking at enterprise imaging and informatics through the lens of cardiology at SIIM

MiE showcases cardiac PET scanner, Ancoris, at SNMMI Provides simultaneous 3D cardiac PET perfusion and CFR

AI tool for Alexa and smart devices detects cardiac arrest in sleeping patients Monitors patients for agonal breathing

Mount Sinai surgeons first in NY to perform minimally-invasive heart bypass surgery Only for highly-skilled surgeons for now

New dye helps control 'lighting' for sharper images of heart May help identify early signs of heart disease

Evaluating the cost-effectiveness of AEDs in the U.S. Insights from Dr. Lars W. Andersen on research he conducted and what it should mean for the future of public defibrillators

The 2019 Heart Rhythm Society scientific sessions: advanced technology in electrophysiology Four key takeaways

A new algorithm could help determine
which heart failure patients would most
likely benefit from expensive treatments
for lethal arrythmias

New machine learning algorithm could decide who is best for heart failure treatment

by John R. Fischer , Staff Reporter
A new machine learning algorithm may help decide who among heart failure patients are the best candidates for expensive treatments that can prevent lethal arrhythmias.

That was the claim made by a group of researchers this past weekend at the International Conference on Nuclear Cardiology and Cardiac CT in Lisbon, where they presented their findings for predicting sudden death from heart failure.

Story Continues Below Advertisement


Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.

“Our model calculated the probability of a sudden arrhythmic event with an area under the curve (AUC) of 0.74, where 1.0 is a perfect prediction and 0.5 is a random result,” said study author professor Kenichi Nakajima, of Kanazawa University Hospital in Japan, in a statement. “This could be used to identify very low-risk patients for whom an ICD or CRT-D is not required, and very high-risk patients who should receive a device. Optimizing risk evaluation in this way will improve the cost-effectiveness of treatment.”

Around one to two percent of adults in developed countries suffer from heart failure, with a high number of deaths taking place suddenly, due to ventricular arrhythmias, especially among those with milder symptoms. While implantable cardioverter defribrillators or cardiac resynchronization therapy with a pacemaker and defibrillator are suggested to reduce this risk, the devices are expensive and do not work in every patient.

Assessing the connection among eight factors used to predict the prognosis of heart failure, the algorithm devised a formula that correlated them to two-year outcomes. The first seven factors were age, sex, heart failure severity (New York Heart Association functional class), heart pumping function (left ventricular ejection fraction), whether heart failure was due to restricted blood supply (ischaemia), B-type natriuretic peptide level in the blood, and kidney function (estimated glomerular filtration rate).

The eighth variable was nuclear imaging parameter, which was heart-to-mediastinum ratio (HMR) of 123Iodine-metaiodobenzylguanidine (MIBG) uptake, a radioisotope that is used to assess the activity of cardiac sympathetic nerves. It is an analogue of norepinephrine, a prescription used for heart failure support. The inclusion of nuclear imaging parameter as a factor stems from previous studies that indicate that HMR can predict cardiac death in patients with heart failure. Measuring it requires an injection of MIBG into the vein, and then using imaging to assess uptake in the heart and upper mediastinum, also known as the center of the thoracic cavity.

The researchers applied the machine learning solution to the cases of 529 heart failure patients with known two-year outcomes for sudden arrhythmic events, including arrhythmic death, sudden cardiac death, appropriate shock from an ICD, and death due to heart failure.

They then followed up with patients two years later, recording 141 events that consisted of 37 sudden arrhythmic events and 104 deaths due to heart failure. The AUC for predicting all events was 0.87, compared to 0.74 and 0.91 for arrhythmic events and heart failure death, respectively.

“This is a preliminary study and we can improve the prediction of arrhythmic events by adding variables and continuing to train the machine learning algorithm,” said Nakajima, adding that a potential barrier that users should be aware of is the cost of MIBG imaging, which is around $2,130–$3,800 in the U.S. “While the costs of the scan may be high, it would be value for money if unnecessary device implantations were avoided.”

Cardiology Homepage

You Must Be Logged In To Post A Comment